This document summarizes a nursing student's drug study of the nonsteroidal anti-inflammatory drug (NSAID) ketorolac, under the brand name Toradol. It lists ketorolac's classification, indications for use in short-term management of moderate to severe pain, common side effects including diarrhea and dizziness, and potential adverse effects involving respiratory, gastrointestinal, central nervous, hematologic, dermatologic, and other systems. The summary concludes with the nursing responsibilities in administering ketorolac such as assessing patient history and condition, having emergency equipment available in case of allergic reaction, protecting drug vials from light, maintaining therapeutic serum levels, and monitoring for signs of adverse reactions
This document summarizes a nursing student's drug study of the nonsteroidal anti-inflammatory drug (NSAID) ketorolac, under the brand name Toradol. It lists ketorolac's classification, indications for use in short-term management of moderate to severe pain, common side effects including diarrhea and dizziness, and potential adverse effects involving respiratory, gastrointestinal, central nervous, hematologic, dermatologic, and other systems. The summary concludes with the nursing responsibilities in administering ketorolac such as assessing patient history and condition, having emergency equipment available in case of allergic reaction, protecting drug vials from light, maintaining therapeutic serum levels, and monitoring for signs of adverse reactions
This document summarizes a nursing student's drug study of the nonsteroidal anti-inflammatory drug (NSAID) ketorolac, under the brand name Toradol. It lists ketorolac's classification, indications for use in short-term management of moderate to severe pain, common side effects including diarrhea and dizziness, and potential adverse effects involving respiratory, gastrointestinal, central nervous, hematologic, dermatologic, and other systems. The summary concludes with the nursing responsibilities in administering ketorolac such as assessing patient history and condition, having emergency equipment available in case of allergic reaction, protecting drug vials from light, maintaining therapeutic serum levels, and monitoring for signs of adverse reactions
This document summarizes a nursing student's drug study of the nonsteroidal anti-inflammatory drug (NSAID) ketorolac, under the brand name Toradol. It lists ketorolac's classification, indications for use in short-term management of moderate to severe pain, common side effects including diarrhea and dizziness, and potential adverse effects involving respiratory, gastrointestinal, central nervous, hematologic, dermatologic, and other systems. The summary concludes with the nursing responsibilities in administering ketorolac such as assessing patient history and condition, having emergency equipment available in case of allergic reaction, protecting drug vials from light, maintaining therapeutic serum levels, and monitoring for signs of adverse reactions
Download as DOCX, PDF, TXT or read online from Scribd
Download as docx, pdf, or txt
You are on page 1of 4
URDANETA CITY UNIVERSITY
San Vicente West, Urdaneta City, Philippines-2428
COLLEGE OF HEALTH SCIENCES Bachelor of Science in Nursing
DRUG STUDY
Name of Student: NAGUI, FERMARY NICOLE A. Date: OCTOBER 19, 2020
Affiliating Hospital: Year/Level: BSN-3
DRUG CLASSIFICATION INDICATION SIDE EFFECTS ADVERSE EFFECT NURSIING RESPONSIBILITY
1. the history (e.g. allergies, renal 1. Respiratory: impairment, etc.) GENERIC NAME: rhinitis, KETOROLAC nonsteroidal anti- Short term Diarrhea and physical hemoptysis, condition of the inflammatory management of Dizziness dyspnea BRAND NAME: patient (reflexes, drugs (NSAIDs moderate to severe Drowsiness 2. GI: GI ophthalmologic and post-up pain, diarrhea, TORADOL Headache audiometric vomiting, Nausea evaluation, nausea DOSAGE: orientation, clotting Stomach Cramps 3. CNS: times, serum 30MG dizziness, CONTRAINDICATION fatigue, electrolytes, etc.) insomnia, 2. In case of headache hypersensitivity, be can cause sure that 4. Hematologic: serious gastrointestina emergency neutropenia, l (GI) adverse events leukopenia, equipment is including bleeding, decreased Hgb available. ulceration and or Hct, bone 3. Drug vials should perforation, of the marrow depres be protected from stomach, small sion light. intestine, or large 5. Dermatologic: 4. To maintain serum intestine, which can sweating, dry levels and control be fatal. mucous membrane, pain effectively, pruritus administer it every six hours. 5. Report any signs of itching, swelling in the ankles, sore throat, easy bruising, etc. Checked by: Date: Clinical Instructor’s Name and Signature